Cytosorbents
CTSO
$0.82
Share price
1.24%
Change (1 day)
-66.71%
Change (1 year)
Categories
Cytosorbents (CTSO) Fails to deliver data
Key failure to deliver metrics for Cytosorbents:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.04 M
- Last 3 months FTD volume: $0.17 M
- Last year FTD volume: $0.32 M
Failures to deliver for Cytosorbents (CTSO) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Cytosorbents (CTSO) - since 2014
Volume in USD (price x number of shares), data since 2014Cytosorbents (CTSO) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.17 M | -21.47% |
| 2023 | $0.22 M | -80.28% |
| 2022 | $1.15 M | -65.45% |
| 2021 | $3.33 M | -77.23% |
| 2020 | $14.65 M | 1346.67% |
| 2019 | $1.01 M | -90.57% |
| 2018 | $10.74 M | -16.22% |
| 2017 | $12.82 M | 1207.64% |
| 2016 | $0.98 M | -94.12% |
| 2015 | $16.68 M | 2394.99% |
| 2014 | $0.66 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Boston Scientific BSX | $65.42 M | $0.10 B | 🇺🇸 USA |
 Hologic HOLX | $1.69 M | $45.32 M | 🇺🇸 USA |
 Meridian Bioscience VIVO | N/A | $0.11 M | 🇺🇸 USA |